Albemarle Co. (NYSE:ALB - Free Report) - Equities research analysts at KeyCorp lowered their FY2025 earnings per share estimates for shares of Albemarle in a report released on Sunday, April 13th. KeyCorp analyst A. Yefremov now forecasts that the specialty chemicals company will earn ($2.13) per share for the year, down from their previous estimate of $5.07. KeyCorp has a "Overweight" rating and a $102.00 price objective on the stock. The consensus estimate for Albemarle's current full-year earnings is ($0.04) per share.
ALB has been the topic of several other research reports. UBS Group dropped their target price on shares of Albemarle from $86.00 to $64.00 and set a "neutral" rating on the stock in a research report on Monday, April 7th. Truist Financial dropped their price target on Albemarle from $85.00 to $65.00 and set a "hold" rating for the company in a research report on Monday. Clarkson Capital assumed coverage on Albemarle in a report on Tuesday, January 14th. They issued a "buy" rating and a $112.00 price objective on the stock. Royal Bank of Canada lowered their target price on shares of Albemarle from $133.00 to $114.00 and set an "overweight" rating on the stock in a research note on Wednesday, February 12th. Finally, Evercore ISI cut shares of Albemarle from an "outperform" rating to an "inline" rating in a research report on Wednesday, February 5th. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $96.05.
Get Our Latest Analysis on Albemarle
Albemarle Price Performance
Shares of ALB stock traded up $0.31 during trading hours on Wednesday, hitting $52.88. 3,117,402 shares of the company's stock were exchanged, compared to its average volume of 2,715,367. The firm has a 50 day moving average of $71.06 and a two-hundred day moving average of $87.20. Albemarle has a fifty-two week low of $49.43 and a fifty-two week high of $137.50. The firm has a market cap of $6.22 billion, a P/E ratio of -4.72 and a beta of 1.59. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39.
Albemarle (NYSE:ALB - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by ($0.49). Albemarle had a negative net margin of 21.93% and a negative return on equity of 1.72%.
Hedge Funds Weigh In On Albemarle
A number of hedge funds and other institutional investors have recently bought and sold shares of ALB. TD Private Client Wealth LLC boosted its stake in shares of Albemarle by 50.4% in the third quarter. TD Private Client Wealth LLC now owns 394 shares of the specialty chemicals company's stock valued at $37,000 after purchasing an additional 132 shares during the period. MassMutual Private Wealth & Trust FSB raised its stake in shares of Albemarle by 48.9% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 414 shares of the specialty chemicals company's stock valued at $36,000 after acquiring an additional 136 shares in the last quarter. First Community Trust NA grew its stake in Albemarle by 55.0% during the 4th quarter. First Community Trust NA now owns 400 shares of the specialty chemicals company's stock worth $34,000 after purchasing an additional 142 shares in the last quarter. Metis Global Partners LLC increased its holdings in Albemarle by 3.9% during the 4th quarter. Metis Global Partners LLC now owns 3,908 shares of the specialty chemicals company's stock worth $336,000 after purchasing an additional 148 shares during the period. Finally, SlateStone Wealth LLC raised its position in Albemarle by 3.3% in the 4th quarter. SlateStone Wealth LLC now owns 4,655 shares of the specialty chemicals company's stock valued at $401,000 after purchasing an additional 150 shares in the last quarter. 92.87% of the stock is currently owned by hedge funds and other institutional investors.
Albemarle Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Friday, March 14th were issued a $0.405 dividend. The ex-dividend date was Friday, March 14th. This represents a $1.62 annualized dividend and a dividend yield of 3.06%. Albemarle's dividend payout ratio is presently -14.46%.
Albemarle Company Profile
(
Get Free Report)
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Further Reading
Before you consider Albemarle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.
While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
